摘要
目的:评价2种神经节苷脂药物治疗新生儿缺氧缺血性脑病的疗效与经济性。方法:采用回顾性分析方法,对凯洛欣与施捷因治疗新生儿缺氧缺血性脑病的疗效进行对比和最小成本分析。结果:2组患者的有效率分别为86.7%、93.3%,无显著性差异(P>0.05);医疗总费用和主药费用分别为(2765.85±484.99)元、(737.50±100.30)元和(4506.70±671.31)元、(2648.80±331.10)元,具有显著性差异(P<0.01)。结论:凯洛欣治疗新生儿缺氧缺血性脑病较佳。
OBJECTIVE： To appraise the therapeutic effects and economics of 2 kinds of gangliosides in treating neonatal hypoxic ischemic enccphalopathy （HIE）.METHODS： A retrospective study was carried out to compare the therapeutic effects between kailuoxin and GM 1 in treating HIE and to make cost- minimization analysis. RESULTS： The effective rates in the 2 groups were 86.7% and 93.3%, respectively, with no significant difference（P 〉0.05）, but the total expenses and cost of the main medical treatment were（2 765.85±484.99）and （737.50± 100.30 ） yuan;（4 506.70± 671.31）and（2 648.80±331.10） yuan, respectively, which demonstrated significant difference（P〈0.0l） between the 2 groups .CONCLUSION： Of the 2 schemes, Kailuoxin is the preferred option for the treatment of neonatal hypoxic ischemic encephalopathy.
出处
《中国药房》
CAS
CSCD
北大核心
2006年第8期592-594,共3页
China Pharmacy
关键词
新生儿缺氧缺血性脑病
凯洛欣
施捷因
疗效
最小成本分析
Neonatal hypoxic ischemic encephalopathy
Kailuoxin
GM-1
Therapeutic effects
Cost- minimization analysis
